Cytomegalovirus Immunity after Vaccination with Autologous Glioblastoma Lysate
نویسندگان
چکیده
منابع مشابه
Cytomegalovirus immunity after vaccination with autologous glioblastoma lysate.
n engl j med 359;5 www.nejm.org july 31, 2008 539 onset breast cancer in two aunts. The patient’s mother had a cerebellar astrocytoma, two vaginal tumors, and a malignant nevus (Fig. 2A). The germ-line PTEN genes of the child and her father had a base change, c.334C→G. Although this change putatively encodes an L112V missense mutation, PTEN messenger RNA (mRNA) analysis instead revealed activat...
متن کاملLong-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination.
Purpose: Patients with glioblastoma have less than 15-month median survival despite surgical resection, high-dose radiation, and chemotherapy with temozolomide. We previously demonstrated that targeting cytomegalovirus pp65 using dendritic cells (DC) can extend survival and, in a separate study, that dose-intensified temozolomide (DI-TMZ) and adjuvant granulocyte macrophage colony-stimulating f...
متن کاملAutologous tumor lysate-loaded dendritic cell vaccination combined with Sunitinib for metastatic renal cell carcinoma
Background The antibodies that block immunological checkpoints have been successfully applied for the treatment of cancer. Similar effects are expected by molecular targeted therapy, which primarily aims to inhibit molecular pathways for tumor cell growth and survival. Such small molecular drugs may modulate the immune system, which raises the possibility that targeted therapy might be effectiv...
متن کاملP-131: Autologous Transplantation Encapsulated Preantral Follicles into Fibrin Hydrogel Supplemented with Platelet Lysate
Background: Recent improvement in treatments of cancer has significantly increased survival rates of cancer patients. Unfortunately these treatments such as chemotherapy and radiotherapy can sever damage to the ovaries. Ovarian cryopreservation prior to chemo/ radiotherapy and auto-transplantation post-treatment can restore fertility to cancer patients. Hypoxia in the transplant from delayed re...
متن کاملA pilot study of autologous tumor lysate-loaded dendritic cell vaccination combined with sunitinib for metastatic renal cell carcinoma
BACKGROUND Sunitinib, a tyrosine kinase inhibitor currently in use for the treatment of metastatic renal cell carcinoma (mRCC), has been reported to modulate immunosuppressive cells such as myeloid-derived suppressor cells (MDSCs) and regulatory T cells (Tregs) in addition to exerting anti-angiogenic effects. We conducted a clinical trial of dendritic cell (DC)-based immunotherapy together with...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: New England Journal of Medicine
سال: 2008
ISSN: 0028-4793,1533-4406
DOI: 10.1056/nejmc0804818